Phase II pilot clinical trial of pazopanib in patients with relapsed or refractory acute myeloid leukemia(AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/01/2010 - 31/12/2016
Description
Keywords: clinical trial
Funder / funding scheme:
- Wirtschaft
Project management at the University of Münster
| Koschmieder, Steffen | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Applicants from the University of Münster
| Koschmieder, Steffen | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Research associates from the University of Münster
| Bormann, Eike | Institute of Biostatistics and Clinical Research (IBKF) |
| Faldum, Andreas | Center of Clinical Trials (ZKS) |
| Gerß, Joachim | Institute of Biostatistics and Clinical Research (IBKF) |
| Urban, Marc | Center of Clinical Trials (ZKS) |